Table 4.
Clinical parameters of HIV-infected subjects included in the HIV primary infection (HPI) cohort
| Subjects | Visit # | CD4 counts 1 | Plasma viral load 2 | Time since infection 3 | Time since inclusion 3 | ART |
|---|---|---|---|---|---|---|
| HPI 01 | V1 | 430 | 35,303 | 2.5 | 0 | No |
| V2 | 520 | 2,301 | 3 | 1 | No | |
| ART at 8 months since infection | V3 | 450 | 24,845 | 3.5 | 2 | No |
| V4 | 350 | 38,395 | 4 | 3 | No | |
| V8 | 310 | 681 | 9 | 7 | Yes | |
| V9 | 690 | 40 | 12 | 10 | Yes | |
| V11 | 690 | 40 | 21 | 16 | Yes | |
| V12 | - | 40 | 21.5 | 19 | Yes | |
| V13 | 650 | 40 | 24 | 22 | Yes | |
| V14 | - | - | 27 | 25 | Yes | |
| HPI 02 | V1 | 407 | 189,343 | 2.5 | 0 | No |
| V2 | 430 | 173,044 | 3.5 | 1 | No | |
| ART at 9.5 months since infection | V3 | 403 | 59,181 | 4 | 2 | No |
| V7 | 396 | 81,037 | 6.5 | 4 | No | |
| V9 | 467 | 74 | 11.5 | 9 | Yes | |
| V10 | 496 | 50 | 13 | 11 | Yes | |
| V11 | 516 | 50 | 16 | 13 | Yes | |
| V12 | 567 | 50 | 20 | 17 | Yes | |
| HPI 03 | V1 | 580 | 86,627 | 1.5 | 0 | No |
| V2 | 540 | 37,335 | 2.5 | 1 | No | |
| ART at 11.5 months since infection | V4 | 740 | 27,348 | 3 | 2 | No |
| V5 | 730 | 20,076 | 3.5 | 3 | No | |
| V7 | 670 | 11,127 | 5.5 | 5 | No | |
| V8 | 530 | 26,574 | 7.5 | 7 | No | |
| V9 | 460 | 85,718 | 10.5 | 10 | No | |
| V10 | 380 | 664 | 13.5 | 13 | Yes | |
| V11 | 660 | 113 | 17 | 17 | Yes | |
| V12 | 640 | 40 | 20 | 19 | Yes | |
| V13 | 780 | 40 | 22 | 22 | Yes | |
| HPI 04 | V1 | 240 | 29,981,000 | 1 | 0 | No |
| V3 | 700 | 129,717 | 2 | 1 | No | |
| ART at 4.5 months since infection | V4 | 340 | 76,626 | 2.5 | 2 | No |
| V7 | 650 | 712 | 5.5 | 5 | Yes | |
| V11 | 670 | 40 | 16 | 15 | Yes | |
| V12 | 870 | 40 | 19 | 18 | Yes | |
| V13 | 830 | 40 | 22 | 21 | Yes | |
| V14 | - | - | 25 | 24 | Yes |
1, cells/μL; 2, HIV-RNA copies per mL plasma (log10); 3, months; ART, antiretroviral therapy.